---
title: "Semaglutide prevents cardiovascular events regardless of weight loss"
date: "2025-10-28T17:01:33.000Z"
publishedDate: "28 octobre 2025"
summary: "Analysis of the SELECT trial—assessing the cardiovascular impact of the diabetes and anti-obesity medication semaglutide (Wegovy, Novo Nordisk)—has found that the use of the drug significantly reduced the risk of major adverse cardiovascular events (MACE) regardless of the amount of weight individuals lost. Findings of the prespecified analysis of the trial, published in The Lancet, [&#8230;] The post Semaglutide prevents cardiovascular events regardless of weight loss appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/semaglutide-prevents-cardiovascular-events-regardless-of-weight-loss/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-10-28-semaglutide-prevents-cardiovascular-events-regardless-of-weight-loss"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/BrandPhoto1_1709582661089-HR-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/semaglutide-prevents-cardiovascular-events-regardless-of-weight-loss/"
---

![Semaglutide prevents cardiovascular events regardless of weight loss](http://cardiovascularnews.com/wp-content/uploads/sites/14/2024/03/BrandPhoto1_1709582661089-HR-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/semaglutide-prevents-cardiovascular-events-regardless-of-weight-loss/*

## L’essentiel

Analysis of the SELECT trial—assessing the cardiovascular impact of the diabetes and anti-obesity medication semaglutide (Wegovy, Novo Nordisk)—has found that the use of the drug significantly reduced the risk of major adverse cardiovascular events (MACE) regardless of the amount of weight individuals lost. Findings of the prespecified analysis of the trial, published in The Lancet, [&#8230;] The post Semaglutide prevents cardiovascular events regardless of weight loss appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/semaglutide-prevents-cardiovascular-events-regardless-of-weight-loss/
